Showing results (1891-1900 of 2,051) with videos related to

Sort By:
Pageof 206
Biorxiv : the Preprint Server for Biology|August 13, 2025
Mechanistic Insights into Dual-Active Liver and Blood-Stage AntiplasmodialsMukul Rawat, Nonlawat Boonyalai, Cindy Smidt, et al.
Cell Systems|May 4, 2024
Acute response to pathogens in the early human placenta at single-cell resolutionRegina Hoo, Elias R Ruiz-Morales, Iva Kelava, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 6, 2021
Inorganic-Cation Pseudohalide 2D Cs<sub>2</sub> Pb(SCN)<sub>2</sub> Br<sub>2</sub> Perovskite Single CrystalChwen-Haw Liao, Chiung-Han Chen, Jueming Bing, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|August 29, 2022
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke PreventionMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2021
Discovery of novel, potent and orally efficacious inhibitor of neutral amino acid transporter B<sup>0</sup>AT1 (SLC6A19)Jigar Desai, Bhaumin Patel, Brijesh Darji, et al.
Global Epidemiology|June 20, 2025
Artificial intelligence for advancing eye care in resource-poor settings: Assessing the predictive accuracy of an AI-model for diabetic retinopathy screening in IndiaRohan Chawla, Prachi Karkhanis, Malay Shah, et al.
Chemico-Biological Interactions|May 11, 2026
Saroglitazar, a novel PPAR-α/γ agonist, modulates thyroid hormone homeostasis through hepatic UGT expression in wistar ratsPraveen Kumar Jain, Laxit K Bhatt, Ashvin K Patel, et al.
Stroke|December 6, 2014
Computed tomography identifies patients at high risk for stroke after transient ischemic attack/nondisabling stroke: prospective, multicenter cohort studyJason K Wasserman, Jeffrey J Perry, Marco L A Sivilotti, et al.
Bioorganic & Medicinal Chemistry Letters|January 4, 2011
Modulation of PPAR subtype selectivity. Part 2: Transforming PPARα/γ dual agonist into α selective PPAR agonist through bioisosteric modificationPandurang Zaware, Shailesh R Shah, Harikishore Pingali, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2018
Identification and preclinical characterization of a novel and potent poly (ADP-ribose) polymerase (PARP) inhibitor ZYTP1Mukul R Jain, Jogeswar Mohapatra, Debdutta Bandhyopadhyay, et al.
Pageof 206